Key facts
- Notable investors include Cambridge Enterprise Ventures.
- Status: Privately Held (backing).
Investors
1- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for Trutina Therapeutics
- ·The full record, as it builds
Funding rounds
No funding rounds for Trutina Therapeutics are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Trutina Therapeutics
Operator of a biotech company focused on developing innovative therapies through experimental development in biotechnology. The company is currently operating in Stealth mode.
- Sector
- Healthcare
- HQ
- Babraham, United Kingdom
- Founded
- 2023
- Employees
- 1
- Ownership
- Privately Held (backing)
Trutina Therapeutics doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Trutina Therapeutics shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Trutina Therapeutics in its N-PORT filings yet. We sweep new filings monthly.